Table 2 STR results
From: A molecular scheme for improved characterization of human embryonic stem cell lines
| Â | Locus ID | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Designation | D5S818 | D13S317 | D7S820 | D16S539 | vWA | TH01 | Amelogenin | TPOX | CSF1PO |
BG01 | 10, 12 | 11, 12 | 10, 11 | 9, 11 | 16, 17 | 7, 9.3 | X, Y | 8 | 10 |
BG01V | 10, 12 | 11, 12 | 10, 11 | 9, 11 | 16, 17 | 7, 9.3 | X, Y | 8 | 10 |
BG02 | 11, 12 | 11 | 12, 14 | 12 | 18, 19 | 8, 9 | X, Y | 11 | 8, 10 |
BG03 | 13 | 8, 12 | 11 | 11, 13 | 16 | 6, 7 | X | 8 | 12 |
I3 | 11, 12 | 12, 14 | 10, 11 | 11, 12 | 16, 17 | 7, 9 | X | 8 | 11, 12 |
I6-P44 | 12 | 8, 11, 12 | 8, 10 | 9, 13 | 16, 17 | 8, 9.3 | X, Y | 10, 11 | 10, 11 |
I6-P47 | 12 | 8, 11 | 8, 10 | 9, 13 | 16, 17 | 8, 9.3 | X, Y | 10, 11 | 10, 11 |
I4 | 11, 12 | 12, 14 | 12, 13 | 11, 12 | 16, 18 | 7, 9 | X | 8 | 12 |
H1 | 9, 11 | 8, 11 | 8, 12 | 9, 13 | 15, 17 | 9.3 | X, Y | 8, 11 | 12, 13 |
H7-P41 | 11, 13 | 11, 12 | 10, 11 | 12, 13 | 14, 15 | 6 | X | 8, 11 | 12 |
H7-P63 | 11, 13 | 11, 12 | 10, 11 | 12, 13 | 14, 15 | 6 | X | 8, 11 | 12 |
H9-P33 | 11, 12 | 9 | 9, 11 | 12, 13 | 17 | 9.3 | X | 10, 11 | 11 |
H9-P78 | 11, 12 | 9 | 9, 11 | 12, 13 | 17 | 9.3 | X | 10, 11 | 11 |
hES2 | 11 | 8, 11 | 9, 11 | 9, 12 | 18, 20 | 7, 9 | X | 8, 12 | 11 |
hES3 | 10, 12 | 9, 12 | 11, 12 | 9 | 17, 18 | 7, 9 | X | 8 | 12 |
SA01 | 12, 13 | 11, 12 | 8, 10 | 12, 13 | 16, 18 | 9.3 | X, Y | 8, 9 | 10, 13 |
SA02 | 12 | 9, 11, 14 | 10, 12 | 12, 14 | 14, 16 | 9, 9.3 | X | 8, 9 | 11, 12 |
SA02.5 | 12 | 9, 11 | 10, 12 | 12, 14 | 14, 16 | 9, 9.3 | X | 8, 9 | 11, 12 |
Relicellâ„¢ hES1 | 11, 12 | 10, 11 | 9, 12 | 11, 12 | 18 | 9 | X | 10, 11 | 10, 11 |
HUES-7 | 11, 13 | 11, 12 | 8, 11 | 11, 12 | 16, 18 | 6, 9.3 | X, Y | 8 | 12 |
NTERA-2 | 9, 12 | 13 | 10, 12 | 11,12,13 | 18, 19 | 9.3 | X, Y | 8 | 10, 12 |